Most not long ago, it has been determined that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in identical places as classical opioid receptors, it binds into a big range of endogenous opioids. Unlike most opioid receptors, this receptor acts as being a scavenger and won't activate a second messenger